Company Filing History:
Years Active: 2017-2018
Title: Innovations by Pano Theodoropoulos
Introduction
Pano Theodoropoulos is an accomplished inventor based in Dallas, Texas. He has made significant contributions to the fields of biochemistry and cancer therapy through his innovative patents. With a total of two patents to his name, Theodoropoulos is recognized for his work in targeting specific biological processes.
Latest Patents
Theodoropoulos's latest patents include groundbreaking inventions. One patent focuses on targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis. This invention provides methods for effectively targeting EBP, which could have implications for cholesterol-related health issues. His other patent involves methods and compositions for selective and targeted cancer therapy. This patent details the use of certain compounds, including benzothiophenes and benzothiazoles, for selectively treating specific adenocarcinomas. The selective toxicity of these compounds may be mediated through SCD1 and/or CYP450 enzymes, such as CYP4F11.
Career Highlights
Pano Theodoropoulos is affiliated with the University of Texas System, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical treatments and therapies.
Collaborations
Theodoropoulos has collaborated with notable colleagues, including Deepak Nijhawan and Jef K De Brabander. These collaborations have likely contributed to the development and refinement of his innovative ideas.
Conclusion
Pano Theodoropoulos is a notable inventor whose work in biochemistry and cancer therapy is paving the way for new medical advancements. His patents reflect a commitment to addressing critical health challenges through innovative solutions.